Biotin-4-aminophenol

CAS No. 901770-40-9

Biotin-4-aminophenol( —— )

Catalog No. M35835 CAS No. 901770-40-9

Biotin-4-aminophenol (BP) is a selective and potent biotin-phenol analog that works by generating free radicals and binding to tyrosine residues in proteins.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 52 In Stock
5MG 76 In Stock
10MG 122 In Stock
25MG 196 In Stock
50MG 293 In Stock
100MG 426 In Stock
500MG 972 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Biotin-4-aminophenol
  • Note
    Research use only, not for human use.
  • Brief Description
    Biotin-4-aminophenol (BP) is a selective and potent biotin-phenol analog that works by generating free radicals and binding to tyrosine residues in proteins.
  • Description
    Biotin-4-aminophenol is a biotin-phenol analog. Biotin-4-aminophenol generates free radicals and conjugates to tyrosine residues in proteins more efficiently and selectively than the previously reported BP1.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    901770-40-9
  • Formula Weight
    335.42
  • Molecular Formula
    C16H21N3O3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (298.13 mM; Ultrasonic (<60°C)
  • SMILES
    C(CCCC(NC1=CC=C(O)C=C1)=O)[C@H]2[C@@]3([C@](CS2)(NC(=O)N3)[H])[H]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ke M, et al. Spatiotemporal profiling of cytosolic signaling complexes in living cells by selective proximity proteomics. Nat Commun. 2021;12(1):71.?
molnova catalog
related products
  • Fantofarone

    Fantofarone is a highly potent Calcium Channel antagonist.

  • Transduction Peptide...

    Transduction Peptide 1 (α II)

  • fulvotomentoside A

    Fulvotomentoside A could decrease overexpression of IL-6 and IL-17A, and increase the expression of specific transcription factor Foxp3 of regulatory T cells significantly in intestine.